Ocugen, Inc.
Company Stats
- Market Cap
- $349.3M
- as of Sep 30, 2026
- Shares Outstanding
- 339.1M
- Free Float
- 96.1%
Income Statement
- Revenue
- $4.4M
- Operating Income
- -$62.9M
- Net Income
- -$67.8M
- EBITDA
- -$60.5M
- FCF Margin, 3Y Avg
- -1206.5%
- FCF Margin, Worst Year
- -1295.0%
Cash Flow
- Free Cash Flow
- -$57.1M
- FCF Yield
- -16.4%
- Owner FCF Yield
- -18.6%
Balance Sheet
- Total Debt
- $31.5M
Returns & Capital
- SBC, 3Y Avg
- $8.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.4M | -$57.1M | -1295.0% |
| FY2024 | $4.1M | -$45.5M | -1122.7% |
| FY2023 | $6.0M | -$72.5M | -1201.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Ocugen to License OCU400 to Roots Pharmaceutical
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back